Verrica Pharmaceuticals Inc. (VRCA): Price and Financial Metrics
VRCA Price/Volume Stats
| Current price | $1.31 | 52-week high | $11.41 |
| Prev. close | $1.45 | 52-week low | $1.04 |
| Day low | $1.31 | Volume | 1,729,400 |
| Day high | $1.54 | Avg. volume | 435,513 |
| 50-day MA | $3.08 | Dividend yield | N/A |
| 200-day MA | $5.83 | Market Cap | 55.57M |
VRCA Stock Price Chart Interactive Chart >
Verrica Pharmaceuticals Inc. (VRCA) Company Bio
Verrica Pharmaceuticals Inc. develops and commercializes dermatological treatments in the United States. The company is advancing its lead product VP-102, a proprietary topical therapy, in various common skin indications, including Molluscum contagiosum and Verruca Vulgaris. It is also developing 2 Phase 3 trials in molluscum contagiosum under NCT03377803 and NCT03377790. The company is based in West Chester, Pennsylvania.
VRCA Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...